Published in Proc Soc Exp Biol Med on April 01, 1963
Use of ultrafiltration for animal virus grouping. Bacteriol Rev (1965) 2.64
Parainfluenza viruses. Clin Microbiol Rev (2003) 2.39
Etiology of acute otitis media in infants and children. Can Med Assoc J (1966) 1.28
Physiochemical characterization of a neonatal calf diarrhea virus. Can J Comp Med (1973) 1.14
A CLASSIFICATION OF VIRUS PARTICLES BASED ON MORPHOLOGY. Can Med Assoc J (1963) 1.08
Taxonomic features of seven serotypes of simian and ape foamy viruses. Infect Immun (1971) 1.08
Multiplication of measles virus in cell cultures. Bacteriol Rev (1966) 1.04
Isolation and characterization of a parvovirus of rabbits. Infect Immun (1977) 0.96
Characteristics of a virus isolated from a feline fibrosarcoma. J Virol (1970) 0.95
Density gradient centrifugation studies on rabies virus. J Bacteriol (1966) 0.89
Isolation and characterization of an Avian adenovirus-associated virus. Infect Immun (1973) 0.89
The development of the virus concept as reflected in corpora of studies on individual pathogens. 4. Rabies--Two millennia of ideas and conjecture on the aetiology of a virus disease. Med Hist (1977) 0.87
A Comparison of the Viruses of Infectious Bovine Rhinotracheitis (IBR), Infectious Pustular Vulvovaginitis (IPV), and Rinderpest: Part I. Studies of Antigenic Relationships. Can J Comp Med Vet Sci (1964) 0.85
RHINOVIRUSES AND RESPIRATORY DISEASE. Bacteriol Rev (1964) 0.81
Thermal and pH stability of feline calicivirus. Infect Immun (1973) 0.81
Production of herpes simplex virus by HeLa cells treated with 5-fluoro-2'-deoxyuridine. Am J Pathol (1968) 0.81
Some biological and physical properties of molluscum contagiosum virus propagated in cell culture. J Virol (1976) 0.80
pH stability studies with avian infectious bronchitis virus (coronavirus) strains. J Virol (1975) 0.79
Recovery and identification of human myxoviruses. Bacteriol Rev (1965) 0.79
Identification and characterization of a second feline herpesvirus. Infect Immun (1974) 0.77
Colorado tick fever virus in cell culture. II. Physical and chemical properties. J Bacteriol (1966) 0.75
The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32
Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med (1954) 6.51
New antigenic variant in Far East influenza epidemic, 1957. Proc Soc Exp Biol Med (1957) 3.82
Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med (1962) 3.32
TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7. Proc Soc Exp Biol Med (1964) 3.15
Characterization and classification of ECHO 28-rhinovirus-coryzavirus agents. Proc Soc Exp Biol Med (1962) 3.06
Antigenic pattern of strains of influenza A and B. Proc Soc Exp Biol Med (1950) 2.70
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. N Engl J Med (1961) 2.66
Purification and characterization of chick embryo interferon. Proc Soc Exp Biol Med (1963) 2.57
The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1951) 2.39
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med (1961) 2.11
Distribution and significance of Asian and other influenza antibodies in the human population. N Engl J Med (1958) 1.97
Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. JAMA (1962) 1.92
System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc Soc Exp Biol Med (1951) 1.88
EFFECTIVE TREATMENT OF EXPERIMENTAL HERPES SIMPLEX KERATITIS WITH NEW DERIVATIVE, 5-METHYLAMINO-2'-DEOXYURIDINE (MADU). Proc Soc Exp Biol Med (1965) 1.84
Adenoviruses: group name proposed for new respiratory-tract viruses. Science (1956) 1.82
Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza. J Immunol (1953) 1.81
Laboratory studies on the 1950 outbreak of influenza. Public Health Rep (1950) 1.67
Recovery of new viruses (coryzavirus) from cases of common cold in human adults. Proc Soc Exp Biol Med (1961) 1.67
Use of living attenuated measles-virus vaccine in early infancy. N Engl J Med (1960) 1.62
Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med (1961) 1.60
Biophysical characterization of the RI (RI-67) viruses. Proc Soc Exp Biol Med (1955) 1.56
Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. Am J Hyg (1955) 1.47
Antibody response in volunteers to Asian influenza vaccine. J Am Med Assoc (1958) 1.45
Studies on the complement fixing antigens of poliomyelitis. I. Demonstration of type and group specific antigens in native and heated viral preparations. J Immunol (1958) 1.44
Search for virus in human malignancies. I. In vitro studies. Proc Soc Exp Biol Med (1962) 1.44
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 1. Laboratory findings in 109 cases. Proc Soc Exp Biol Med (1961) 1.43
Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine. Proc Soc Exp Biol Med (1956) 1.43
ATTEMPTS TO INTERRUPT VIRUS TUMORIGENESIS BY IMMUNIZATION USING HOMOLOGOUS "BJORKLUND-TYPE" ANTIGEN. Proc Soc Exp Biol Med (1963) 1.41
Elimination of nonspecific components from viral antigens by fluorocarbon. J Immunol (1958) 1.36
Epidemiologic investigations with respiratory disease virus RI-67. Am J Public Health Nations Health (1955) 1.34
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle. J Immunol (1961) 1.33
INTERRUPTION OF SV-40 VIRUS TUMORIGENESIS USING IRRADIATED HOMOLOGOUS TUMOR ANTIGEN. Proc Soc Exp Biol Med (1964) 1.32
Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med (1962) 1.31
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE. Proc Soc Exp Biol Med (1964) 1.30
Influenza antibodies in the population of the USA; an epidemiological investigation. Bull World Health Organ (1953) 1.30
Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. Am J Dis Child (1962) 1.25
Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg (1957) 1.24
A safe high-speed blendor for processing infectious materials. J Lab Clin Med (1958) 1.21
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus. J Immunol (1961) 1.20
Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. Public Health Rep (1951) 1.20
Factors influencing tumor induction in hamsters by vacuolating virus, SV. Proc Soc Exp Biol Med (1963) 1.20
Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. Ann Intern Med (1962) 1.20
EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS. Proc Soc Exp Biol Med (1964) 1.19
ADDITIONAL RHINOVIRUS SEROTYPES. Proc Soc Exp Biol Med (1965) 1.19
Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci (1957) 1.18
Effect of Westphal lipid A on viral activities in mice and hamsters. Proc Soc Exp Biol Med (1962) 1.15
Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. Bull World Health Organ (1957) 1.11
A pattern of antigen variation. Fed Proc (1952) 1.10
A guinea pig potency test for adenovirus vaccine. J Immunol (1960) 1.10
Dissociation of poliomyelitis virus from neutralizing antibody. Virology (1958) 1.10
Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition. J Immunol (1952) 1.10
Electron microscopy of type 4 adenovirus strain R1-67. Virology (1957) 1.06
Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. J Immunol (1958) 1.04
A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT. Am Rev Respir Dis (1964) 1.03
Clinical and laboratory studies in patients with respiratory disease caused by adenoviruses (RI-APC-ARD agents). Am J Med (1956) 1.03
Immunologic studies of measles. Am J Hyg (1961) 1.00
IMMUNOLOGIC, CHEMOTHERAPEUTIC AND INTERFERON APPROACHES TO CONTROL OF VIRAL DISEASE. Am J Med (1965) 0.98
In vivo and in vitro studies of serological specificity among viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1952) 0.98
Grouping and occurrence of RI (prototype RI-67) viruses. Proc Soc Exp Biol Med (1955) 0.97
Immunogenic response to killed measles-virus vaccine. Studies in animals and evaluation of vaccine efficacy in an epidemic. Am J Dis Child (1962) 0.96
Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy. Am J Public Health Nations Health (1962) 0.96
A new viral agent associated with erythema infectiosum. Ann N Y Acad Sci (1957) 0.96
Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions. Am J Dis Child (1962) 0.95
CHARACTERIZATION OF CHICK EMBRYO INTERFERON INDUCED BY A DNA VIRUS. Proc Soc Exp Biol Med (1965) 0.94
Administration of Enders' live measles virus vaccine with human immune globulin. JAMA (1962) 0.94
Development of a purified poliomyelitis virus vaccine. JAMA (1961) 0.92
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS. Proc Soc Exp Biol Med (1964) 0.91
Pathogenicity and oncolytic capacity of RI virus strain RI-67 in man. J Lab Clin Med (1956) 0.91
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 3. EFFICACY AND TOXICITY STUDIES IN MAN. N Engl J Med (1964) 0.91
RESPIRATORY SYNCYTIAL VIRUS. Am Rev Respir Dis (1963) 0.91
Antigenic variation of influenza viruses. Annu Rev Microbiol (1954) 0.90
Group-specificity of psittacosis-lymphogranuloma venereum group skin test antigens in lymphogranuloma venereum patients. J Lab Clin Med (1958) 0.89
CLINICAL-EPIDEMIOLOGIC FINDINGS IN CORYZAVIRUS INFECTIONS. Am Rev Respir Dis (1963) 0.89
Efficacy of and indications for use of adenovirus vaccine. Am J Public Health Nations Health (1958) 0.88
FURTHER TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES AND MYCOPLASMA, WITH CORRELATIVE REVIEW. Proc Soc Exp Biol Med (1965) 0.87
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. II. Development and appraisal of potency of SF-4 (shipping fever) virus vaccine. J Immunol (1961) 0.87
Respiratory viruses and respiratory virus vaccines. Am Rev Respir Dis (1963) 0.87
Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity. J Immunol (1958) 0.87